South Korea reports record high 383,665 new COVID-19 cases - KDCA
South Korea reports record high 383,665 new COVID-19 cases - KDCA

South Korea reports record high 383,665 new COVID-19 cases - KDCA
South Korea reaffirmed its commitment to comprehensive vaccine support for Asia's developing countries during a virtual session hosted by US Secretary of State Antony Blinken, according to Seoul's foreign ministry Tuesday.
It joins the ranks of authorised vaccines made by AstraZeneca Inc, Moderna Inc, Pfizer and Johnson & Johnson's Janssen.
It is a stage of evaluating the safety and effectiveness of the treatment, and the clinical trial phase 2 will be conducted on 70 patients next year.
The announcement comes as South Korea has inoculated 29.2% of its population as of Saturday, putting it on track to meet a target of 70% by September.
An investigation was concluded on 11 out of 47 people who died within days of receiving Covid-19 vaccines by AstraZeneca and Pfizer Inc, the Korea Disease Control and Prevention Agency (KDCA) said.
At the beginning of the pandemic more than a year ago, North Korea described its efforts to keep out the virus as a “matter of national existence.”
Health authorities had previously been reluctant to expand the use of rapid antigen tests and other forms of fast testing, which could produce results within 30 minutes but are less accurate than standard laboratory tests.
South Korea was opening dozens of free Covid-19 testing sites in the greater Seoul area, as the country registered additional 718 new cases Monday amid a surge in infections.
South Korea reported on Wednesday its highest daily rise in novel coronavirus cases since early March as outbreaks from churches around the capital spread, prompting a warning of a nationwide wave of infections.
The so-called SARS-CoV-2 virus dies one to two weeks after infecting and proliferating inside respiratory cells, doctors at the National Medical Center in Seoul told reporters on Wednesday. Pieces of the virus’s genetic material may remain in cells and be detected by a nucleic acid test a month or two after infection, underscoring the limitation of testing, they said.